JUPITER, FL - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company with a market capitalization of $40.39 million, has announced a strategic partnership with Zina Biopharmaceuticals,

The Jupiter price surged over 15% after plans for a token burn and buy backs were revealed as this layer-2 ICO surpasses $15.5 million.

While some view it as a positive move for long-term growth, others worry it could lead to monopolistic behavior and harm innovation in the Solana ecosystem.

JUP price corrects 10% after a strong rally, but smart money accumulation remains high. A bullish EMA setup could support a rebound.

Lindsey Tilton turned her love for paddleboarding into a full-time hobby that has her paddling across the seven seas.

Jupiter, Solana’s leading decentralized exchange (DEX) aggregator, will use 50% of its protocol fee revenue to repurchase $JUP tokens.

The facility will have an annual production capacity of 4.2 GW for solar cells and 3.6 GW for modules, contributing to the expansion of India’s solar manufacturing ecosystem.

While market conditions and certain geopolitical shifts may influence the short-term outlook for some of its initiatives, ASX-listed Jupiter Mine’s five-year strategy remains solid and well-aligned with its long-term objectives,

Jupiter acquires Moonshot, a launchpad topping finance app charts, and integrates SonarWatch for a Solana-based portfolio tracker.

The Jupiter price plunged 12% as investors shift focus to a new Solana Layer-2 project offering a 281% staking APY and a $567M token airdrop.